Healio

RelabotulinumtoxinA demonstrates rapid onset, durability for frown lines, crow’s feet

Please provide your email address to receive an email when new articles are posted on . Both phase 3b studies met their primary endpoints of improved frown lines and crow’s feet. A majority of ...
Business Wire

Results From Galderma’s Phase IIIb Trials Demonstrate Rapid and Long-Lasting Effect of RelabotulinumtoxinA on Crow’s Feet and Frown Lines

ZUG, Switzerland--(BUSINESS WIRE)--Galderma announced today topline results from two phase IIIb trials investigating RelabotulinumtoxinA for the treatment of glabellar lines (GL – frown lines) and ...
Business Wire

TOXINS 2024: Galderma’s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow’s Feet Simultaneously

ZUG, Switzerland--(BUSINESS WIRE)--Galderma announced today positive topline results from the phase III READY-3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of ...